---
title: "Black Diamond Therapeutics (BDTX.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/BDTX.US/norm.md"
symbol: "BDTX.US"
name: "Black Diamond Therapeutics"
parent: "https://longbridge.com/en/quote/BDTX.US.md"
datetime: "2026-05-20T15:08:25.846Z"
locales:
  - [en](https://longbridge.com/en/quote/BDTX.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/BDTX.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/BDTX.US/norm.md)
---

# Black Diamond Therapeutics (BDTX.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.1600 | -0.2648 | -0.1500 | -0.1900 | 0.9800 |
| ROE | -33.39% | -50.73% | -26.27% | -30.82% | 201.22% |
| Revenue | - | 0.0000 | - | - | 70.00M |
| Net income | -9.04M | -15.12M | -8.50M | -10.56M | 56.54M |
| Operating income | -11.26M | -10.26M | -10.98M | -13.42M | 54.53M |
| Gross margin | - | - | - | - | 100.00% |
| Net margin | - | - | - | - | 80.77% |
| Profit quality | - | - | - | - | 102.10% |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 132.92M | 143.01M | 157.73M | 166.38M | 176.25M |
| Leverage | 1.27 | 1.27 | 1.25 | 1.25 | 1.25 |
| BVPS | 1.82 | 1.96 | 2.22 | 2.33 | 2.50 |
| Turnover | 0.0000 | 0.5270 | 0.4736 | 0.4425 | 0.4392 |
| Cash & STI | 118.26M | 128.65M | 135.50M | 142.83M | 152.40M |
| Inv & Rec | - | - | - | - | - |
| LT assets | 9.10M | 9.67M | 17.80M | 18.67M | 19.54M |
| Net debt | -100.38M | -109.87M | -115.83M | -122.08M | -130.81M |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -10.23M | -6.79M | -7.85M | -9.16M | 53.41M |
| Investing CF | 19.50M | -2.89M | 8.59M | -59.15M | 8.55M |
| Financing CF | -185000.00 | -196000.00 | 134000.00 | -116000.00 | 32000.00 |
| Free CF | -7.76M | -5.13M | -5.74M | -7.26M | 31.16M |
| OCF coverage | - | - | - | - | - |
| Repaid & issued | - | - | - | - | - |
| CapEx | - | - | - | - | - |